...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Poster

Same abstract that we discussed mid-May. Poster is not up yet and probably won't be until 6/22.

 

Share
New Message
Please login to post a reply